Can-Fite BioPharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 422,373 | 0.0282% |
| Institutions | 75,805,894 | 5.06% |
| General Public | 1,420,900,226 | 94.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 46,962,846 | US$328.9k | 0% | 0.01% | |||
| 13,879,500 | US$97.2k | 40.2% | no data | |||
| 6,015,900 | US$42.1k | 0% | no data | |||
| 5,544,600 | US$38.8k | 3.12% | no data | |||
| 1,092,174 | US$7.6k | 0% | 0.09% | |||
| 910,774 | US$6.4k | 0% | no data | |||
| 900,000 | US$6.3k | 0% | no data | |||
| 263,433 | US$1.8k | 0% | no data | |||
| 180,000 | US$1.3k | 0% | no data | |||
| 165,900 | US$1.2k | 0% | no data | |||
| 141,000 | US$987.8 | 0% | no data | |||
| 133,567 | US$935.3 | 0% | no data | |||
| 24,240 | US$169.9 | 0% | no data | |||
| 7,200 | US$50.3 | 0% | no data | |||
| 6,000 | US$41.9 | 0% | no data | |||
| 1,133 | US$8.4 | 0% | no data |